LivaNova to Announce First-Quarter 2025 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, has scheduled its first-quarter 2025 earnings conference call for Wednesday, May 7, 2025 at 1 p.m. London time (8 a.m. Eastern Time). The company will release its Q1 2025 financial results before the call.
Investors can access the audiocast through www.livanova.com/events, with recommended login 10 minutes before the start. For telephone access, U.S. participants should dial +1 833 470 1428, while international callers can use +1 929 526 1599, with access code 047836. A replay will remain available on the company website for 90 days after the call.
LivaNova PLC (Nasdaq: LIVN), un'azienda leader nel settore della tecnologia medica, ha programmato la sua conferenza sui risultati finanziari del primo trimestre 2025 per mercoledì 7 maggio 2025 alle 13:00 ora di Londra (8:00 ora orientale). L'azienda pubblicherà i risultati finanziari del Q1 2025 prima della chiamata.
Gli investitori possono accedere all'audiocast tramite www.livanova.com/events, con accesso consigliato 10 minuti prima dell'inizio. Per l'accesso telefonico, i partecipanti statunitensi devono comporre il numero +1 833 470 1428, mentre i chiamanti internazionali possono utilizzare il numero +1 929 526 1599, con codice di accesso 047836. Una registrazione sarà disponibile sul sito web dell'azienda per 90 giorni dopo la chiamata.
LivaNova PLC (Nasdaq: LIVN), una empresa líder en tecnología médica, ha programado su conferencia de resultados financieros del primer trimestre de 2025 para miércoles 7 de mayo de 2025 a la 1 p.m. hora de Londres (8 a.m. hora del Este). La compañía publicará sus resultados financieros del Q1 2025 antes de la llamada.
Los inversores pueden acceder al audiocast a través de www.livanova.com/events, con inicio recomendado 10 minutos antes de la llamada. Para acceso telefónico, los participantes de EE. UU. deben marcar +1 833 470 1428, mientras que los llamantes internacionales pueden usar +1 929 526 1599, con el código de acceso 047836. Una repetición estará disponible en el sitio web de la empresa durante 90 días después de la llamada.
LivaNova PLC (Nasdaq: LIVN), 시장 선도 의료 기술 회사,는 2025년 5월 7일 수요일 오후 1시(런던 시간, 동부 표준시 8시)에 2025년 1분기 실적 컨퍼런스 콜을 예정했습니다. 회사는 통화 전에 2025년 1분기 재무 결과를 발표할 것입니다.
투자자는 www.livanova.com/events를 통해 오디오 방송에 접속할 수 있으며, 시작 10분 전에 로그인하는 것이 좋습니다. 전화 접속의 경우, 미국 참가자는 +1 833 470 1428로 전화해야 하며, 국제 전화자는 +1 929 526 1599를 사용하고 액세스 코드 047836을 입력해야 합니다. 호출 후 90일 동안 회사 웹사이트에서 재생이 가능합니다.
LivaNova PLC (Nasdaq: LIVN), une entreprise leader dans le domaine de la technologie médicale, a programmé sa conférence téléphonique sur les résultats financiers du premier trimestre 2025 pour mercredi 7 mai 2025 à 13h00, heure de Londres (8h00, heure de l'Est). L'entreprise publiera ses résultats financiers du T1 2025 avant l'appel.
Les investisseurs peuvent accéder à l'audiocast via www.livanova.com/events, avec une connexion recommandée 10 minutes avant le début. Pour l'accès téléphonique, les participants américains doivent composer le +1 833 470 1428, tandis que les appelants internationaux peuvent utiliser le +1 929 526 1599, avec le code d'accès 047836. Un enregistrement sera disponible sur le site web de l'entreprise pendant 90 jours après l'appel.
LivaNova PLC (Nasdaq: LIVN), ein führendes Unternehmen im Bereich Medizintechnologie, hat seine Telefonkonferenz zu den Finanzergebnissen des ersten Quartals 2025 für Mittwoch, den 7. Mai 2025, um 13:00 Uhr Londoner Zeit (8:00 Uhr Eastern Time) angesetzt. Das Unternehmen wird die Finanzzahlen für Q1 2025 vor der Konferenz veröffentlichen.
Investoren können auf den Audiocast über www.livanova.com/events zugreifen, wobei eine Anmeldung 10 Minuten vor Beginn empfohlen wird. Für den telefonischen Zugang sollten US-Teilnehmer +1 833 470 1428 wählen, während internationale Anrufer +1 929 526 1599 nutzen können, mit dem Zugangscode 047836. Eine Wiederholung wird für 90 Tage nach der Konferenz auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2025 results on Wednesday, May 7, 2025 at 1 p.m.
The audiocast will be accessible at www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial +1 833 470 1428 (if dialing from within the
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in
Safe Harbor Statement
This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding the next Company conference call. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250326313185/en/
LivaNova Investor Relations and Media Contacts
+1 281-895-2382
Briana Gotlin
VP, Investor Relations
InvestorRelations@livanova.com
Deanna Wilke
VP, Corporate Communications
Corporate.Communications@livanova.com
Source: LivaNova PLC